Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Drospirenone; Ethinylestradiol
Gedeon Richter Plc
G03AA; G03AA12
Drospirenone; Ethinylestradiol
0.03mg/3 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
Marketed
2010-08-20
1 PACKAGE LEAFLET: INFORMATION FOR THE USER ELVINA 0.03MG/3MG FILM-COATED TABLETS ethinylestradiol and drospirenone IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES (CHCS): - They are one of the most reliable reversible methods of contraception if used correctly. - They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more weeks - Please be alert and see your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”). READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them. - If you get any side effect, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Elvina is and what it is used for 2. What you need to know before you use Elvina 3. How to take Elvina 4. Possible side effects 5. How to store Elvina 6. Contents of the pack and other information 1. WHAT ELVINA IS AND WHAT IT IS USED FOR - Elvina is a contraceptive pill and is used to prevent pregnancy. - Each tablet contains a small amount of two different female hormones, namely drospirenone and ethinylestradiol. - Contraceptive pills that contain two hormones are called “combination” pills. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE ELVINA GENERAL NOTES Before you start using Elvina you should read the information on blood clots in section 2. It is particularly important to read the symptoms of a blood clot – see Section 2 “Blood clots”. Before you can begin taking Elvina, your doctor will ask you some questions about your personal health history and that of your close relatives. The doctor will a Read the complete document
Health Products Regulatory Authority 08 March 2023 CRN00D7P9 Page 1 of 17 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Elvina 0.03mg/3mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 0.03 mg ethinylestradiol and 3 mg drospirenone. Excipients with known effect: Each film-coated tablet contains 48.17 mg of lactose monohydrate and 0.070 mg of soya lecithin. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White or almost white, round, biconvex film-coated tablet. Engraving on one side: “G63”, other side is without engraving. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception. The decision to prescribe Elvina should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Elvina compares with other combined hormonal contraceptives (CHCs) (see sections 4.3 and 4.4). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of administration: oral use Posology _How to take Elvina _ The tablets must be taken every day at about the same time, if necessary with a little liquid, in the order shown on the blister pack. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval, during which time a withdrawal bleed usually occurs. This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started. _How to start Elvina _ - No preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). - Changing from another combined hormonal contraceptive (combined oral contraceptive (COC), vaginal ring or transdermal patch) The woman should start with Elvina preferably on the day after the last active tablet (the last tablet containing the active substances) of her previous COC; but at the latest on the day following Read the complete document